SBIR-STTR Award

Dermatologist-level detection of suspicious pigmented skin lesions from high-resolution full-body images
Award last edited on: 10/20/21

Sponsored Program
STTR
Awarding Agency
NSF
Total Award Amount
$255,999
Award Phase
1
Solicitation Topic Code
BM
Principal Investigator
Davood Tashayyod

Company Information

Lumo Imaging LLC

155 Gibbs Street Suite 530
Rockville, MD 20850
   (215) 895-5849
   N/A
   www.lumosimaging.com

Research Institution

Johns Hopkins University - Baltimore

Phase I

Contract Number: 2127051
Start Date: 8/1/21    Completed: 7/31/22
Phase I year
2021
Phase I Amount
$255,999
The broader impact/commercial potential of this Small Business Technology Transfer Program (STTR) Phase I project is to improve outcomes in dermatology and enable improved clinical care in the absence of specialists. The proposed technology enables cost-effective screening for cancer, psoriasis, atopic dermatitis, and other inflammatory skin conditions. In the United States, psoriasis affects about 8 million people while about 31.6 million people in the United States have some form of eczema, including atopic dermatitis. The proposed system generates a highly magnified image of the skin for analysis by a clinician or an artificial-intelligence based automated system. This Small Business Technology Transfer Program (STTR) Phase I project integrates several subsystems: 1) a scanner and software to capture and reconstruct super high-resolution (dermatoscope level) model of the entire skin surface of patients in a matter of minutes; 2) a multispectral illumination system to provide more information than currently available from a typical white-light systems, potentially leading to superior sensitivity and specify in lesion detection and classification; and 3) a system to find and classify lesions automatically from high-resolution images. This system advances the automated classification of images beyond those filtered previously by a clinician. Moreover, the system's UV illuminations system potentially can be used in a photodynamic treatment regimen. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----